Bypass Surgery Shows Long-Term Survival Advantage Over Stenting
This article was originally published in The Gray Sheet
Executive Summary
Drug-eluting stent manufacturers with an eye toward multi-vessel and diabetic-specific indications face a new hurdle in the recent release of observational data pointing to lower mortality among patients receiving bypass surgery compared with stenting